CorMedix Inc. announced the formation of a new Scientific Advisory Board (SAB) comprised of esteemed experts in nephrology, infectious disease, medical nutrition, and pediatric oncology. The SAB's mission will be to provide strategic and scientific advice as CorMedix advances DefenCath™ toward a potential commercial launch and looks to pursue DefenCath lifecycle expansion opportunities. Scientific Advisory Board Members: Saravanan Balamuthusamy, M.D., FASN, FASDIN.

Nephrologist, PPG Healthcare, Chairman, Division of Internal Medicine, Medical College of Ft. Worth; Sara Bonnes, M.D., M.S., FACP. Associate Professor of Medicine, Physician Nutrition Specialist, Mayo Clinic; Stanley Crittenden, M.D., FASN.

Nephrologist, Chief Medical Officer, Evergreen Nephrology; Aru Narendran, M.D., Ph.D., FAAP. Professor of Pediatrics, Oncology, Biochemistry, and Molecular Biology, Physiology and Pharmacology, Cumming School of Medicine, University of Calgary; Hannah Newman, MPH, CIC. Director of Infection Prevention, Northwell Health; Bruce Polsky, M.D., MACP, FIDSA.

Professor and Chairman, Department of Medicine, Associate Dean, Faculty, NYU Long Island School of Medicine; Prayus Tailor, M.D., FASN. Nephrologist, Nephrology Associates, PA and Medical Director, Fresenius Medical Care, North America; Jonathan Waitman, M.D. Assistant Professor in Medicine, Medical Director of Specialized Nutrition Support, Weill Cornell Medical College.